https://pittplusme.org/study/1474
Falcon 2 Study
We're sorry. This study is closed and no longer recruiting participants.
STUDY BASICS
Have you been diagnosed with Nonalcoholic Steatohepatitis (NASH) and compensated liver cirrhosis? If so, you may be eligible to participate in a study to help researchers find out how effective and how safe a study drug, called BMS-986036, is in reducing the liver damage caused by NASH. Involves up to 16 visits. Travel reimbursement is provided.
IRB: SSU00075215
- Bristol Myers Squibb – MB130-069, A phase 2b Randomized, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of BMS-986036 (PEG-FGF21) in Adults with Nonalcoholic Steatohepatitis (NASH) and Compensated Liver Cirrhosis (Pro00025786)
AGE:
18 - 75
VISITS:
16 visits
LOCATION:
UPMC Montefiore Hospital, Oakland
COMPENSATION:
Up to $800.00 for completing all visits and procedures
SHARE STUDY
